NCT00351052View on ClinicalTrials.gov

Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

December 31, 2001

Study Completion Date

September 30, 2004

Conditions
Atopic Dermatitis
Interventions
DRUG

Pimecrolimus

Pimecroliums cream 1 % bid.

DRUG

Placebo

Vehicle control (placebo) bid.

Trial Locations (1)

Unknown

Investigational Site

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00351052 - Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis | Biotech Hunter | Biotech Hunter